Earnings Labs
Aligos Therapeutics, Inc. logo

Aligos Therapeutics, Inc. (ALGS) Earnings Dates & History

NASDAQ·Healthcare·Biotechnology

$6.31

Mkt Cap $43.23M

EPS — Estimate vs Actual

Revenue — Estimate vs Actual

Quarterly History

Q1 2026

Mar 5, 2026

$440.00K$169.00K-61.59%-$2.49-$1.91+23.19%
Q4 2025

Nov 6, 2025

$266.67K$741.00K+177.87%-$2.09-$3.04-45.45%
Q3 2025

Aug 6, 2025

$433.33K$965.00K+122.69%-$2.35-$1.53+34.89%
Q2 2025

May 6, 2025

$500.00K$311.00K-37.80%-$2.80-$2.11+24.64%
Q1 2025

Mar 10, 2025

$500.00K$629.00K+25.80%-$2.63-$3.41-29.66%
Q4 2024

Nov 6, 2024

$433.33K$1.27M+192.85%-$2.15-$3.07-42.79%
Q3 2024

Aug 6, 2024

$1.06M-$4.00$0.75+118.75%
Q2 2024

May 7, 2024

$986.00K-$4.75-$5.50-15.79%
Q1 2024

Mar 12, 2024

$1.60M$2.68M+67.56%-$6.75-$5.50+18.52%
Q4 2023

Nov 2, 2023

$1.60M$3.24M+102.44%-$12.00-$10.25+14.58%
Q3 2023

Aug 3, 2023

$6.89M-$12.50-$10.75+14.00%
Q2 2023

May 4, 2023

$1.42M$2.72M+91.76%-$12.25-$13.25-8.16%
Q1 2023

Mar 9, 2023

$1.72M$3.54M+105.64%-$12.25-$12.75-4.08%
Q4 2022

Nov 2, 2022

$750.00K$4.11M+447.47%-$14.25-$11.00+22.81%
Q3 2022

Aug 4, 2022

$3.69M-$16.25-$11.75+27.69%
Q2 2022

May 4, 2022

$2.18M$2.57M+17.74%-$16.50-$21.00-27.27%
Q1 2022

Mar 10, 2022

$367.00K-$20.75-$22.25-7.23%
Q4 2021

Nov 4, 2021

$1.63M$1.54M-5.68%-$20.75-$19.50+6.02%
Q3 2021

Aug 5, 2021

$1.54M$1.54M+0.00%-$20.25-$19.75+2.47%
Q2 2021

May 10, 2021

$1.07M$910.00K-15.09%-$22.50-$18.50+17.78%
Q1 2021

Mar 23, 2021

-$0.82-$1.09-32.93%
Q4 2020

Nov 25, 2020

$2.03M-$0.78-$11.00-1310.26%
Q4 2020

Oct 19, 2020

-$0.95
Q1 2020

Mar 31, 2020

-$0.91
Q4 2019

Dec 31, 2019

-$0.83
Q3 2019

Sep 30, 2019

-$0.64
Q2 2019

Jun 30, 2019

-$0.46
Q1 2019

Mar 31, 2019

-$0.46
Q2 2018

Jun 30, 2018

-$0.16
Q1 2018

Mar 31, 2018

-$0.16